USE OF GENETIC POLYMORPHISMS THAT ARE ASSOCIATED WITH THE EFFECTIVENESS OF THE TREATMENT OF AN INFLAMMATORY DISEASE.

摘要

Use of pimecrolimus in the manufacture of a drug for the treatment of pediatric atopic dermatitis in a selected patient population, where the patient population is selected from those who have either (i) a TT genotype in a locus located -1031 of the transcription initiation site of the human TNF gene, or (ii) an AA or AC genotype in the ASN60THR LTA locus of the human LTA gene.